The potential of depressive symptoms to identify cognitive impairment in ageing
Panagiotis Alexopoulos(Klinikum rechts der Isar), Polychronis Εconomou(University of Patras), Efthimios Dardiotis(University of Thessaly), Laura Perna(Max Planck Institute of Psychiatry), Paraskevi Sakka(Greek Association of Alzheimer's Disease and Related Disorders), Μarina Charalampopoulou(University of Patras), Mary Yannakoulia(Harokopio University of Athens), Mary H. Kosmidis(Aristotle University of Thessaloniki), Kostas Siarkos(National and Kapodistrian University of Athens), Apostolos Batsidis(University of Ioannina), Nikolaos Scarmeas(Eginition Hospital), Antonios Politis(Johns Hopkins University), Iracema Leroi(Trinity College Dublin), Maria Skondra(University of Patras), Panagiotis Felemegkas(University of Patras), Everina Katirtzoglou(National and Kapodistrian University of Athens), Georgios M. Hadjigeorgiou(University of Bonn), Christos Bountoulis(University of Piraeus), Robert Perneczky(Klinikum rechts der Isar)
Cited by 5
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Body Fat Mass and Macronutrient Intake in Relation to Circulating Soluble Leptin Receptor, Free Leptin Index, Adiponectin, and Resistin Concentrations in Healthy Humans
|The Journal of Clinical Endocrinology & Metabolism|2003|430
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380